What Is the Role of Body Composition Assessment in HCC Management?

Area of Science:

• Medical research
• Oncology
• Nutritional science

Background:

• Body composition (BC) assessment provides nutritional insights beyond classical parameters like BMI and albumin.
• Skeletal muscle abnormalities and adipose tissue characteristics significantly impact outcomes in cirrhotic and oncologic patients, including HCC.
• Despite its potential, BC assessment is not standard in pre-therapeutic workups due to data heterogeneity, lack of standardization, and limited prospective studies.

Purpose of the Study:

• To review existing evidence on the prognostic role of body composition in hepatocellular carcinoma (HCC) patients.
• To explore how different body composition metrics influence outcomes in HCC patients undergoing various treatments.

Main Methods:

• Systematic review of published literature on body composition assessment in HCC.
• Analysis of studies correlating body composition parameters with patient outcomes (morbidity, mortality).

Main Results:

• Abnormalities in skeletal muscle mass are linked to poorer outcomes in HCC.
• The distribution and radiodensity of adipose tissue are critical determinants of HCC prognosis.
• Heterogeneity in BC data and assessment methods limits its current clinical integration.

Conclusions:

• Body composition analysis holds significant prognostic value for HCC patients.
• Further standardization and prospective studies are needed to integrate BC assessment into routine HCC management.
• BC assessment can refine risk stratification and personalize therapeutic strategies for HCC.